DIPEPTIDIDE PEPTIDASE-4 (DPP4 / CD26) AS THE PERIPHERAL BIOMARKER OF IL-13 ACTIVATION IN THE ASTHMATIC EFFECT

摘要

13 antagonist, (iv) to prognosticate the outcome of treating an IL-13 mediated condition or disorder with a specific IL-13 antagonist. The disclosure further provides assay kits for the detection of DPP4, as well as computer implemented diagnostic methods.